Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00851214 · ClinicalTrials.gov registry record
Use of Non Invasive Hemodynamic Cardiovascular Monitoring to Evaluate Emergency Department Patients
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 40
- Enrollment target
NCT00851214: Completed study, sponsored by Henry Ford Health System.
NCT00851214 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00851214 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study is an observational prospective pilot trial that utilizes finger cuff non invasive hemodynamic monitoring (NexfinHD Monitor) to assess 4 different groups (CHF/COPD, Trauma, Sepsis, Stroke) of patients on arrival to the Emergency Department and to document the changes seen in these hemodynamics with acute therapies.
Interventions
- DEVICE NexfinHD Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-06 |
What the finished NCT00851214 record still lists
NCT00851214 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which NexfinHD Monitor is the first listed.
NCT00851214 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00851214 about?
NCT00851214 is a clinical study titled "Use of Non Invasive Hemodynamic Cardiovascular Monitoring to Evaluate Emergency Department Patients". This study is an observational prospective pilot trial that utilizes finger cuff non invasive hemodynamic monitoring (NexfinHD Monitor) to assess 4 different groups (CHF/COPD, Trauma, Sepsis, Stroke) of patients on arrival to the Emergency Department and to document the changes seen in these hemodyn...
What is the current status of trial NCT00851214?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00851214?
The interventions under investigation include: NexfinHD Monitor (DEVICE).
Who is sponsoring clinical trial NCT00851214?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia